Search

everythinglearnresearchcommunity

for

Search:↓

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

SHPro® improved urinary symptoms and erectile function in men and is safe.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

PNKP is essential for keeping adult mouse progenitor cells healthy and growing normally.

Urinary PSA could be an early marker for enlarged prostate.

Finasteride may reduce prostate cancer risk.

Provenge extends prostate cancer survival by about 4 months.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

PDRN helps repair tissue and improve wound healing with a high safety profile.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Proretinal nanoparticles improve skin absorption and reduce irritation of topical retinoids.

Progesterone significantly reduces neuroblastoma tumor growth without harming healthy cells.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Seven new genetic risk areas for prostate cancer were found.

Polynucleotides HPT improves Asian skin tone, firmness, and glow safely.